Efficacy of Bushen Huatan Decoction in the Treatment of Polycystic Ovary Syndrome - Trial NCT05976308
Access comprehensive clinical trial information for NCT05976308 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by Jiangxi University of Traditional Chinese Medicine and is currently Recruiting. The study focuses on Polycystic Ovary Syndrome. Target enrollment is 68 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Jiangxi University of Traditional Chinese Medicine
Timeline & Enrollment
Phase 1/2
Sep 01, 2023
Dec 01, 2025
Primary Outcome
Ovulation rate
Summary
Polycystic ovary syndrome (PCOS) is a common reproductive disease associated with endocrine
 and metabolic disorders. Some studies have shown that Chinese herbal medicine is beneficial
 for PCOS, but the efficacy of Chinese herbal medicine in the treatment of PCOS is not clear,
 because the quantity of pre-clinical data was limited and the quality of clinical evidence
 was variable. Therefore, this randomized double-blind placebo-controlled trial aim to
 evaluate the efficacy of Chinese herbal medicine (Bushen Huatan Decoction) in women with
 PCOS.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05976308
Non-Device Trial